ClinicalTrials.gg
RecruitingNCT06671002CARES for KidsUpdated Oct 20, 2026

Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial

A Phase 4 interventional study of NSAID and Opioid in Surgery and Pain, Post Operative, sponsored by University of Michigan. Recruiting at 9 sites in United States. Open to participants aged 12 Years to 20 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by University of Michigan · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.
Updated Oct 20, 20265 sites addedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
12 Years to 20 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative — 22 open to participants now, 25 under way, 3 of them phase 3. A drug class: Anti-Inflammatory Agents, Non-Steroidal · Pain, Postoperative.

Planned enrollment
5th of 229
900 · median 90
Started
2025
with 9 others
Phase 4
84 of 229
12 open now
Primary completion
2026-10
later than 9 of 24 live
Registered
210th of 229
by date

Among the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, this one is the 5th largest by planned enrollment, is one of 10 that started in 2025, is one of 84 in phase 4, reaches primary completion later than 9 of the 24 other live ones, and was the 210th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

22 of the 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative are open now, in 8 countries. Recruiting first, the newest first:

16 more — sign in →

By country, each count listing its studies:

All 22 open studies →

About Anti-Inflammatory Agents, Non-Steroidal

A class of medicines: which ones, and the studies of each, are on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 12 Years to 20 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 229 studies testing Anti-Inflammatory Agents, Non-Steroidal in Pain, Postoperative, or all of them as a file.
02

Study summary

This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eligible to enroll. Eligible participants will be randomized to prescription of 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) plus acetaminophen or low dose opioids with the NSAIDs plus acetaminophen. The key question the study seeks to answer is which option will have the best outcomes and with the fewest side effects?

03

Conditions studied

  • Surgery
  • Pain, Post Operative

Browse trials for

Keywords

  • Medications after surgery
  • NSAIDS
  • Acetaminophen
  • Opioids
  • Analgesics, non-narcotic
  • Tonsil removal
  • Gallbladder removal
  • Knee scope
  • Analgesics, opioid
04

Who can participate

Ages eligible
12 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No significant analgesic medication use before surgery as defined in the protocol. For this study, we define significant analgesic medication use before surgery as prescriptions reported by the child or caregiver for 6 days or more of opioid medications in the past 90 days (aligning with American Pediatric Guidelines that were published in September 2024 after the project was funded), excepting surgical team prescriptions within the week of surgery.
  • Undergo one the following: tonsil removal (with or without adenoid removal), gallbladder removal (laparoscopic), and knee scope (arthroscopy).

Exclusion criteria

Exclusion Criteria:

  • Anticipated other surgery within 12 months
  • Anticipated of \<12 months
  • Those that have legal guardians (due to special permission to enroll in trials)
  • Participants with complex chronic conditions per the Pediatric Medical Complexity Algorithm (e.g., trisomy 21)
  • Patients with to non-steroidal anti-inflammatory drug (NSAID) drugs in the NSAID arm, opioid drugs in the opioid arm, or acetaminophen will be excluded.
  • Liver disease
  • Acute psychiatric instability (defined as current uncontrolled severe depression, severe post-traumatic stress disorder (PTSD), or suicidal ideation), substance use disorder not in remission or treatment, and history of diversion of controlled substances (opioids)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
900 participants (estimated)

Study arms

  • Other
    Acetaminophen/NSAID regimen

    Drug: NSAID · Drug: Acetaminophen

  • Other
    Acetaminophen/NSAID/Opioid regimen

    Drug: Opioid · Drug: Acetaminophen · Drug: Ibuprofen

Interventions

  • DrugAnti-Inflammatory Agents, Non-SteroidalStudies of Anti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory Agents, Non-Steroidal pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Once randomized to this group the surgical team will elect to prescribe 1 of the following treatment options for post-discharge pain: * Ibuprofen 10 milligrams(mg)/kilogram (kg) (maximum 600mg) by mouth every 6 hours around the clock for 2 days, then as needed for pain thereafter (40 doses) * Celecoxib 6mg/kg (maximum 400mg) by mouth once then 3 mg/kg (maximum 200mg) every 12 hours around the clock for 2 days, then as needed for pain thereafter (40 doses)

    Also known as: Ibuprofen, Celecoxib

  • DrugOpioidsStudies of OpioidsOpioids pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Once randomized to this group the surgical team will elect to prescribe for 1 of the following treatment options to be given post procedure for post-discharge pain: * Oxycodone 0.1 mg/kg (maximum 5 mg) by mouth every 4 to 6 hours as needed for pain, number 10 doses. * Hydromorphone 0.04 mg/kg (maximum mg) by mouth 4 to 6 hours as needed, number 10 doses

    Also known as: Oxycodone, Hydromorphone

  • Participants will receive 15mg/kg up to 1000mg by mouth every 6 hours around the clock for the first 2 days after discharge from surgery then as needed thereafter (40 doses)

  • Ibuprofen 10mg/kg (maximum 600 mg) by mouth every 6 hours around the clock for 2 days after discharge from surgery then as needed thereafter (40 doses)

06

What researchers measure

Primary outcomes

  1. Effectiveness outcome - Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 14 days post-surgery

    This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.

    Time frame: 14 days post-surgery, and up to 12 months after surgery

  2. Safety outcome - number and severity of any adverse medication-related symptoms over 14 days post-surgery

    Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 14 days post-surgery.

    Time frame: 14 days post-surgery, and 1 month after surgery

Secondary outcomes

  1. Patient Reported Outcomes Measurement Information System (PROMIS) Pediatric Sleep Disturbance v1.0 short form 4a

    This is a 4-question survey in which participants will rate statements pertaining to quality of sleep. Participants will also rate sleep quality as very poor (5), poor (4), fair (3), good (2), or very good (1).

    Time frame: Baseline and 1 month after surgery

  2. Patient Global Impression of Change (PGIC)

    The perception of improvement or worsening after treatment will be assessed by the patient global impression of change PGIC (range 0-7).

    Time frame: Day 7 up to 12 months after surgery

  3. PROMIS Pediatric Pain Interference scale (Short form-8a)

    This is an 8-question survey in which participants will rate statements pertaining to how pain interferes with activities and function.

    Time frame: Baseline up to 12 months after surgery

  4. Pain Catastrophizing Scale (PCS)

    This is a 6-question survey in which participants will rate statements pertaining to their experience of pain.

    Time frame: Baseline up to 12 months after surgery

  5. Pediatric Quality of Life Inventory Short Form 15

    There are 15 questions with four scales for function related to physical, emotional, social, and school dimensions for adolescents. Participants answer questions from never (0) to almost always (4).

    Time frame: Baseline up to 12 months after surgery

  6. Quality of Recovery (QoR) 15

    There are 15 questions assessed on a scale of 1-10, with 0 being none of the time and 10 being all of the time, 10 being the better outcome.

    Time frame: Day 3, 1 week, and 2 weeks after surgery

  7. Patient Health Questionnaire (PHQ-2)

    There are 2 questions that are completed to screen for depression. Participants answer from not at all (0) to Nearly every day (3). The scores range from 0-6 with a higher score indicating higher levels of depression.

    Time frame: Baseline up to 12 months after surgery

  8. Generalized Anxiety Disorder (GAD-2)

    There are 2 questions that are completed to screen for anxiety. Participants answer from not at all (0) to Nearly every day (3). The scores range from 0-6 with a higher score indicating higher levels of anxiety.

    Time frame: Baseline up to 12 months after surgery

  9. Brief Screening Instrument for Adolescent Tobacco, Alcohol, and Drug Use

    This is a 6-question survey about the participants' use of tobacco, alcohol and drugs.

    Time frame: Baseline up to 12 months after surgery

  10. National Survey on Drug Use and Health Questions on Opioid Misuse

    This is a one question survey that assesses opioid misuse defined as use that is more than prescribed, for non pain-related reasons, or in a way not prescribed by a doctor.

    Time frame: Baseline up to 12 months after surgery

  11. New prolonged opioid use

    One question that will assess opioid prescription fills to identify new prolonged opioid use after surgery

    Time frame: Up to 12 months after surgery

  12. Acute pain based on The Michigan Body Map

    Participants will document/mark on this image map to identify areas in which acute pain was felt.

    Time frame: Up to 12 months after surgery

  13. Chronic pain based on Body Map

    Participants will document/mark on this image map to identify areas in which persistent or recurrent pain was felt.

    Time frame: Up to 12 months after surgery

  14. Chronic pain based on Brief Pain Inventory (BPI) pain intensity score up to 12 months after surgery

    One question survey in which the participants rate pain intensity recorded (0-10), ten being the worst.

    Time frame: to 12 months after surgery

  15. Healthcare Utilization related to pain

    Participants will answer questions about their healthcare utilization related to pain for the following three events: (1) postoperative clinical interactions related to pain in the form of patient messages, phone calls, and non-routine clinic visits related to pain, (2) emergency room visits, and (3) hospitalizations. The study team will also review health record for the same events.

    Time frame: Up to 12 months after surgery

  16. Analgesic medication use

    Participants will answer questions about their analgesic medication use for acetaminophen, NSAIDs, opioids, and other medications, including prescription fills, over-the-counter use, and consumption. The study team will also review health record for prescription fills.

    Time frame: Up to 12 months after surgery

07

Study locations

4 of 9 sites recruiting
08

References and documents

Publications

  • Lee JS, Bicket MC, Mansfield SA, Rabbitts JA, Van Horn A, Perrone EE, Chua KP, Voepel-Lewis T, Waljee J, Brummett C, Hutmacher C, Li Y, Kelley-Quon LI; CARES for Kids Investigators. US multicentre randomised controlled trial protocol: Comparing Analgesic Regimen Effectiveness and Safety after surgery trial for Kids (CARES for Kids). BMJ Open. 2026 May 28;16(5):e118728. doi: 10.1136/bmjopen-2026-118728. PubMed 42208996 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results of the trial that is not subject to restrictions based on data sharing agreements (e.g., prescription drug monitoring program data), after deidentification

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Anticipated summer 2029 with no end date

Access criteria: Investigators can access the IPD and supporting information for analyses related to aims in the proposal. The proposed used of the data needs to be approved by a review committee and the sponsor. Proposals may be submitted up to 36 months after data availability, after which data will be available in a data warehouse but without investigator support.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Oct 2026, 21 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 21 months is above that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2024
First posted
Nov 4, 2024
StartActual
Jan 10, 2025
Primary completionEst.
Oct 16, 2026
CompletionEst.
Oct 31, 2027
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
5 sites added
Show 5 added (5 United States)
  • Phoenix Children's · Phoenix, United States
  • Children's Hospital Colorado · Aurora, United States
  • Kapi'olani Medical Center for Women & Children · Honolulu, United States
  • Cincinnati Children's · Cincinnati, United States
  • Children's Wisconsin · Milwaukee, United States
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    5 sites added
    Show 5 added (5 United States)
    • Phoenix Children's · Phoenix, United States
    • Children's Hospital Colorado · Aurora, United States
    • Kapi'olani Medical Center for Women & Children · Honolulu, United States
    • Cincinnati Children's · Cincinnati, United States
    • Children's Wisconsin · Milwaukee, United States
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06671002
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Mark Bicket, MD, PhD (Associate Professor of Anesthesiology, University of Michigan) — Principal investigator
First posted
Nov 4, 2024
Start date
Jan 10, 2025
Primary completion
Oct 16, 2026 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Sarah Clark
Contact
sarahmcl@umich.edu
734-232-0324
Mark Bicket, MD, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Anti-Inflammatory Agents, Non-Steroidal · Opioids · Ibuprofen

Start the discussion